Your support helps NAMA make a difference.Treasurer: J.L. Sotheran, PhD, CMA Please confirm your Donation with our Treasurer (with a copy to the Membership Director). |
Similar Posts
Answer two
FALSE! These are three of the many myths of methadone. Few drugs have been studied as extensively in humans as methadone. Hundreds of thousands of people have been maintained on methadone, many since the treatment was developed over thirty years ago. Methadone and methadone therapy are so tremendously misunderstood (for many reasons) that any study…
Recovery Advocates Sharpen Their Skills By Bob Curley
Feature Story Join Together Online June 3, 2004. Seeking to empower grassroots advocates for addiction recovery, the group Faces and Voices of Recovery (FAVOR) recently held the first in a planned series of national advocacy-training sessions in Braintree, Mass. Cosponsored by a pair of regional advocacy groups, the New England Alliance of Addiction Recovery Communities…
Drugs and Conditions That Impact On the Action of Methadone
Methadone Metabolism Methadone was once considered to be pretty much the same for every patient. Thus, it was believed that narcotic blockade began at 60 mg/day for about 90% of the patients an adequate dose occurred at 80 mg/day. The measuring of serum methadone levels have shown that metabolism can vary significantly for many patients. …
Methadone Awareness Test – Answer Four
FALSE! Methadone patients feel the normal range of pain, and due to cross tolerance with methadone may need significantly _higher_ doses of narcotic analgesics administered _more_ frequently. Reference: Dole, V.P.; Nyswander, M.E. & Kreek, M.J. Narcotic blockade. Archives of Internal Medicine, 1966(October) 118: 304-309 Back to the Methadone Test
Optimizing response to methadone maintenance treatment: use of higher-dose methadone.
J Psychoactive Drugs 1999 Apr-Jun;31(2):95-102 Maxwell S, Shinderman M Center for Addictive Problems Chicago, Illinois 60610 Using signs, symptoms and serum methadone levels to guide evaluation, the authors treated 164 patients in a methadone maintenance program with doses of methadone exceeding 100 mg/d. The mean dose of these higher dose (HD) patients was 211 mg/d…
The First Patient Advocate’s Illumination Award Sunday, October 7th
The First Patient Advocate’s Illumination Award Sunday, October 7th The Advocate’s Illumination Award is presented to an individual and/or treatment program whose persistence in the search of solutions to the myriad problems of addictive disease, has significantly improved the experience and outcome of treatment. Inscription The Opioid Agonist Treatment Advocacy Community with heartfelt thanks and…